A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis Suppurativa
Clinical trial NCT04856930 · COMPLETED
Trial details
- NCT number
- NCT04856930
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-07
- Primary completion
- 2022-07-15
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.